Cohance share price today: ₹481.35 at the close on Thursday, 29 October 2026, up ₹5.30 (+1.11%) from the previous close of ₹476.05. Cohance Lifesciences (NSE: COHANCE) traded between ₹473.20 and ₹493.05 that day, on 14.96 lakh shares.
Cohance support and resistance: the nearest support is ₹474.98 and the nearest resistance ₹483.00 on the 15-minute chart. Cohance 52-week high and low: ₹830.00 and ₹266.70; it closed 42.0% below that high and 80.5% above that low.
The chart above is live while NSE trades (9:15 am to 3:30 pm IST, Monday to Friday): candles from 1 minute to daily, 10 years of daily history and 140+ indicators and studies, free to open with no account.
At the close on Thursday, 29 October 2026
Prices from NSE. The chart above streams them live while the market is open.
The near levels: the ones the chart's Auto Support & Resistance overlay draws on Cohance's 15-minute chart, nearest first, below and above the price at the close, ₹481.35. They come from the last 30 days of 15-minute candles (30 Sept to 29 Oct). A level is a price where the share's swings turned before; the more turns, the more established it is. Each level is the middle of the narrow band where its swings turned, so it can sit slightly above or below a day's exact high or low.
Nearest: ₹474.98 (2 turns, the latest at 2:00 pm on 29 Oct)
Next: ₹471.23 (3 turns, the latest at 3:15 pm on 28 Oct)
Nearest: ₹483.00 (1 turn, the latest at 3:00 pm on 29 Oct)
Next: ₹493.05 (1 turn, the latest at 10:00 am on 29 Oct)
Levels describe where the price reacted before. They are not a forecast or a recommendation, and the price can move straight through them. On the chart above, pick 15m and switch on Overlays → Auto Support & Resistance (free with an account) to see them drawn; on any other timeframe it draws that timeframe's own levels.
How far Cohance's price at the close (₹481.35) is from its close a week, a month, 3 months and 6 months earlier, and from its 52-week high and low. Price change only: dividends are not added back.
High ₹830.00: the price closed 42.0% below it.
Low ₹266.70, on 9 Mar 2026: the price closed 80.5% above it.
Prices stream as Cohance trades on NSE, from 9:15 am to 3:30 pm IST, and the newest candle forms as you watch. Outside market hours the chart shows the last session, ending at its close.
Candles from 1 minute to daily — 1, 3, 5, 10, 15 and 30 minutes, 1 to 4 hours, and daily — with 10 years of daily history to scroll back through, as candles, bars, line or Heikin Ashi.
140+ indicators and studies (moving averages, RSI, MACD, Bollinger Bands, VWAP, Supertrend, volume profile and more), drawing tools and symbol compare. Opening the chart needs no account; a second indicator, the overlays such as Auto Support & Resistance, price alerts and Alpha AI need a free account.
Price, open, high, low, previous close and volume: NSE, at the 29 Oct close.
52-week high and low: NSE's own figures.
Market cap, PE and price to book: Cohance's filed results (consolidated) at the price above, the same figures as Cohance's financials page.
Support and resistance: Alphave's Auto Support & Resistance on 15-minute candles, 30 Sept to 29 Oct.
Delivery and the 20-day average volume: NSE's daily delivery and volume data.
Price history: closing prices from Alphave's daily NSE candles.
Alphave is run by its founder, Amit Meena. If a figure here looks wrong, email [email protected] and it will be checked and corrected.
Cohance Lifesciences is the renamed entity created by merging Advent International's CDMO platform (built on RA Chem Pharma and ZCL Chemicals) with listed Suven Pharmaceuticals. It is a contract development and manufacturing organisation supplying pharma intermediates, APIs and specialty chemical actives to global innovator pharma and agrochemical companies, with capabilities in areas such as antibody-drug-conjugate payloads and linkers. Revenue is driven by long-cycle CDMO contracts tied to innovator molecule volumes.
Cohance share price today: ₹481.35 at the close on Thursday, 29 October 2026, up ₹5.30 (+1.11%) from the previous close of ₹476.05. Cohance Lifesciences (NSE: COHANCE) traded between ₹473.20 and ₹493.05 that day, on 14.96 lakh shares. NSE trades again from 9:15 am IST on the next trading day.
On the 15-minute chart (the last 30 days of 15-minute candles, to 29 Oct), against the price of ₹481.35 at the close, Cohance has support at ₹474.98 (2 turns, the latest at 2:00 pm on 29 Oct) and ₹471.23 (3 turns, the latest at 3:15 pm on 28 Oct), and resistance at ₹483.00 (1 turn, the latest at 3:00 pm on 29 Oct) and ₹493.05 (1 turn, the latest at 10:00 am on 29 Oct). These are prices where the share turned before, not a forecast. The chart's Auto Support & Resistance overlay draws them, and every other timeframe's own levels.
At the top of this page. The Cohance (NSE: COHANCE) chart is live while NSE trades, from 9:15 am to 3:30 pm IST, with candles from 1 minute to daily, 10 years of daily history and 140+ indicators, and it opens free with no account.
Cohance's 52-week high is ₹830.00 and its 52-week low ₹266.70 (9 Mar 2026). At the 29 Oct close of ₹481.35, it is 42.0% below the high and 80.5% above the low.
Cohance's market capitalisation is ₹18,416 crore at the 29 Oct close (38.26 crore shares at ₹481.35 each), and its PE ratio 173.4 on consolidated net profit attributable to shareholders over the last four quarters (Q2 FY26 to Q1 FY27), or 102.8 on FY26 profit; its price to book is 4.71. Its next results are due on 6 November 2026, and the PE will change with them. The figures behind them are on Cohance's financials page.
At the 29 Oct close (₹481.35), Cohance is +6.06% over 1 week, +5.12% over 1 month, +11.60% over 3 months and +2.95% over 6 months, on price alone. The chart above has 10 years of daily history.
COHANCE (ISIN INE03QK01018). It is part of the Nifty Smallcap 250, Nifty 500 and Nifty Smallcap 100. Sector: Pharma & Health, Healthcare Services.
No. This page and the chart show market data for information only. They are not a recommendation to buy or sell any security.
Prices from NSE, at the 29 Oct close. Market data for information only, not a recommendation to buy or sell.